“a decreasing trend”

But in Gruen zones 1 and 7, the last follow-up BMD presented a decreasing trend (P<0.05).

While the Shannon index showed an increasing trend and the Simpson index a decreasing trend, these differences were not statistically significant ( p > 0.05), suggesting improved overall richness and diversity in the YC group.

Bax and c-Caspase3 expression were increased, while Bcl2 expression showed a decreasing trend ( p < 0.05) ( Figure 4 I).

Conversely, propionic acid content exhibited a decreasing trend, demonstrating lower concentrations at days 30 and 70 than at day 7 ( p < 0.05). 3.3.

A decreasing trend was observed in the PACV scores as the level of education and income level of the participants increased ( p < 0.05).

Although LIPG, PILIN1, and AQP7 were not significantly affected, they also exhibited a decreasing trend (P > 0.05).

Among the children younger than 6 years, as the FIQ increased, both the OAHI and SBII showed a decreasing trend ( p < 0.05).

With ongoing treatment, both groups showed a decreasing trend in B cell proportions, with statistically significant differences observed within each group (all P < 0.05).

The results displayed a decreasing trend in the prevalence of osteoporosis across the HDL-c and APOA1 tertiles ( p < 0.05).

Moreover, the percentage of MDSCs decreased while the percentage of CD8 + T cells increased in the IPI‐549+anti‐PD‐1 group and showed a decreasing trend compared with the anti‐PD‐1 group for both PBMCs and MSLs (most Groups p < 0.05).

Conversely, height and BMD levels show a decreasing trend in this group ( P < 0.05).

Notably, the prevalence among Hispanics increased from 10 to 12%, while there is a decreasing trend in other demographics ( P = 0.05).

The Cochran-Armitage trend test showed an overall increasing trend in the prevalence of DPN, DPVD, hypertension, DN, CI, lithiasis, DR, DF, and anemia with increasing age ( P < 0.05), while there was a decreasing trend in the prevalence of FL ( P < 0.05).

Results showed a decreasing trend in Foxp3 expression in the offspring of the Emu mice ( P < 0.05, Fig. 3 b).

Stomach cancer also showed a decreasing trend among women (AAPC −3.2 and −3.6%, p < 0.05).

A positive statistical test (Z>0 and p <0.05) indicated an increasing trend, while a negative test (Z<0 and p <0.05) indicated a decreasing trend.

In comparison, Tr and Ci demonstrated lower sensitivity to Cs treatment, while Gs displayed a decreasing trend with increasing Cs concentration (20.62–40.73%, p < 0.05) ( Figure 3 B–D).

Relative to the M group, Gran showed a significant decrease in the Ori-H group ( P < 0.05), and Gran showed a decreasing trend in the Ori-L group ( P > 0.05).

2 C, vs EtOH control, p < 0.001; vs FMT-non-BQT, p < 0.01) indices, while Chao1 and ACE indices showed a decreasing trend ( p > 0.05, Fig. 2 D, E).

Although IL‐1β concentrations in the LCs‐treated group showed a decreasing trend compared to the 5FU group, this difference did not reach statistical significance ( p > 0.05).

Other BCFA treatments did not significantly affect TLR4 and NF-κB expression levels compared to the LPS group, although a decreasing trend was noted ( p > 0.05). 3.10.

Although no significant difference was noted among groups in Shannon index, there was still a decreasing trend, except for M20, suggesting that morel intervention did not significantly affect the microbiota evenness ( p > 0.05). 3.2.

Shannon index showed a decreasing trend after SGLT2i treatment ( p > 0.05).

A decreasing trend was also observed in total TC levels ( P > 0.05).

Moreover, the ash of the whole fish displayed a decreasing trend ( p < 0.05), with no notable differences among the DCP0, DCP10, DCP20, and DCP30 groups ( p > 0.05).